Reporting of Compounded Drug Problems Needs Improvement: FDA
The FDA is working on new policies and actions to shore up the safety of compounding pharmacies, after discovering some have avoided reporting adverse events as required by law.
The FDA is working on new policies and actions to shore up the safety of compounding pharmacies, after discovering some have avoided reporting adverse events as required by law.